GSWM
SRPT icon

Golden State Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Golden State Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64
Closed -$1.23K – 1760
2025
Q3 		$1.23K Hold
64
– – ﹤0.01% 1477
2025
Q2 		$1.09K Hold
64
– – ﹤0.01% 1425
2025
Q1 		$4.08K Sell
64
-55
-46% -$5.79K ﹤0.01% 1211
2024
Q4 		$14.5K Buy
+119
New +$14.6K ﹤0.01% 855
2020
Q2 		– Sell
-25
Closed -$2K – 809
2020
Q1 		$2K Buy
+25
New +$2.86K ﹤0.01% 874
2019
Q4 		– Sell
-25
Closed -$2K – 815
2019
Q3 		$2K Hold
25
– – ﹤0.01% 987
2019
Q2 		$3K Hold
25
– – ﹤0.01% 950
2019
Q1 		$3K Buy
+25
New +$3.21K ﹤0.01% 993

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return